Q&A: EASL recommends Tecentriq plus Avastin as standard of care for HCC

Q&A: EASL recommends Tecentriq plus Avastin as standard of care for HCC

Recently the European Association for the Study of the Liver updated its clinical practice guidelines for management of hepatocellular carcinoma.Healio Gastroenterology spoke with Bruno Sangro, MD, director of the liver unit at Clínica Universidad de Navarra, and professor of internal medicine at the University of Navarra School of Medicine, in Pamplona, about EASL’s latest update to the recommendations for systemic therapy of HCC.Healio: Why did EASL decide to update the recommendations for systemic therapy of HCC?Sangro: The recommendations that were in the last version of theRead More

Share on facebook
Share on twitter
Share on linkedin